Detection of Pretreatment Circulating Tumor DNA Predicts Recurrence after High-Dose Proton Beam Therapy for Early-Stage Non-Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics · 2023
DOI: 10.1016/j.ijrobp.2023.02.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2023. Verfasst von Masaki Nakamura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan; Division of Particle Therapy, Exploratory Oncology Research and…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Circulating Tumor DNA, Proton Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
For early-stage non-small cell lung cancer (ES-NSCLC), surgery and high-dose radiation therapy have similar outcomes, leading to the use of stereotactic body radiation therapy (SBRT) as a curative treatment option even if patients are eligible for surgery.1 Proton beam therapy (PBT) is also considered to have outcomes comparable to SBRT for ES-NSCLC.2 However, regarding the recurrence pattern after radiation therapy, including SBRT and PBT, while local recurrence occurs in approximately 10% of patients, regional and/or distant recurrence occurs in 20% to 30% of patients, which is an important issue to overcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan; Division of Particle Therapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan. Electron…
- Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan; Division of Particle Therapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.
- Department of Radiological Technology, National Cancer Center Hospital East, Chiba, Japan.
- Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Chiba, Japan.
- Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.
Zitieren
APA
Nakamura, M., Kageyama, S. I., Hirata, H., Tochinai, T., Hojo, H., Motegi, A., Kanai, A., Suzuki, Y., Tsuchihara, K., & Akimoto, T. (2023). Detection of Pretreatment Circulating Tumor DNA Predicts Recurrence after High-Dose Proton Beam Therapy for Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2023.02.021
Vancouver
Nakamura M, Kageyama SI, Hirata H, Tochinai T, Hojo H, Motegi A, et al. Detection of Pretreatment Circulating Tumor DNA Predicts Recurrence after High-Dose Proton Beam Therapy for Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 2023. doi:10.1016/j.ijrobp.2023.02.021
BibTeX
@article{Nakamura2023,
author = {Nakamura, Masaki and Kageyama, Shun-Ichiro and Hirata, Hidenari and Tochinai, Taku and Hojo, Hidehiro and Motegi, Atsushi and Kanai, Akinori and Suzuki, Yutaka and Tsuchihara, Katsuya and Akimoto, Tetsuo},
title = {Detection of Pretreatment Circulating Tumor DNA Predicts Recurrence after High-Dose Proton Beam Therapy for Early-Stage Non-Small Cell Lung Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2023},
doi = {10.1016/j.ijrobp.2023.02.021}
}
EUVIMED